FR2449093B1 - - Google Patents

Info

Publication number
FR2449093B1
FR2449093B1 FR8003143A FR8003143A FR2449093B1 FR 2449093 B1 FR2449093 B1 FR 2449093B1 FR 8003143 A FR8003143 A FR 8003143A FR 8003143 A FR8003143 A FR 8003143A FR 2449093 B1 FR2449093 B1 FR 2449093B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8003143A
Other languages
French (fr)
Other versions
FR2449093A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH154579A external-priority patent/CH641810A5/de
Priority claimed from CH17480A external-priority patent/CH645378A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2449093A1 publication Critical patent/FR2449093A1/fr
Application granted granted Critical
Publication of FR2449093B1 publication Critical patent/FR2449093B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR8003143A 1979-02-16 1980-02-13 Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments Granted FR2449093A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH154579A CH641810A5 (en) 1979-02-16 1979-02-16 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them
CH17480A CH645378A5 (en) 1980-01-10 1980-01-10 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them

Publications (2)

Publication Number Publication Date
FR2449093A1 FR2449093A1 (fr) 1980-09-12
FR2449093B1 true FR2449093B1 (US07534539-20090519-C00127.png) 1983-07-29

Family

ID=25683752

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8003143A Granted FR2449093A1 (fr) 1979-02-16 1980-02-13 Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments

Country Status (19)

Country Link
US (1) US4477448A (US07534539-20090519-C00127.png)
AT (1) AT374806B (US07534539-20090519-C00127.png)
CA (1) CA1161032A (US07534539-20090519-C00127.png)
DE (1) DE3005012A1 (US07534539-20090519-C00127.png)
DK (1) DK53780A (US07534539-20090519-C00127.png)
ES (2) ES488651A0 (US07534539-20090519-C00127.png)
FI (1) FI800381A (US07534539-20090519-C00127.png)
FR (1) FR2449093A1 (US07534539-20090519-C00127.png)
GB (2) GB2046734B (US07534539-20090519-C00127.png)
IE (1) IE49395B1 (US07534539-20090519-C00127.png)
IL (1) IL59391A (US07534539-20090519-C00127.png)
IT (1) IT8047922A0 (US07534539-20090519-C00127.png)
MY (1) MY8500128A (US07534539-20090519-C00127.png)
NL (1) NL8000894A (US07534539-20090519-C00127.png)
NZ (1) NZ192873A (US07534539-20090519-C00127.png)
PH (1) PH17926A (US07534539-20090519-C00127.png)
PT (1) PT70834A (US07534539-20090519-C00127.png)
SE (2) SE8000982L (US07534539-20090519-C00127.png)
YU (1) YU40280A (US07534539-20090519-C00127.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3165922D1 (en) * 1980-03-28 1984-10-18 Biochemie Gmbh New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production
CH648038A5 (de) * 1981-01-19 1985-02-28 Sandoz Ag 7-((carboxymethoxyimino)-1h-pyrazol-3-yl-acetyl)amino-3-desacetoxy-3-(1-methyl-1h-tetrazol-5-yl-thio)cephalosporansaeure und salze, verfahren zur herstellung und verwendung.
GB2125033B (en) * 1982-07-23 1985-08-29 Servipharm Ltd Cephalosporins
US4698338A (en) * 1986-02-19 1987-10-06 Eli Lilly And Company 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins
US5688964A (en) * 1996-02-13 1997-11-18 Eastman Kodak Company Process for preparing a acylhyrazino pyrazole derivative
ATE268990T1 (de) * 1999-09-24 2004-07-15 Agro Kanesho Co Ltd Insektizide und akarizide
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
EA024559B1 (ru) 2009-05-06 2016-09-30 Лаборэтори Скин Кэа, Инк. Композиции для нанесения на кератинизированную поверхность кожи млекопитающего и способ доставки
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins

Also Published As

Publication number Publication date
NZ192873A (en) 1984-07-31
FR2449093A1 (fr) 1980-09-12
FI800381A (fi) 1980-08-17
ES8203848A1 (es) 1982-04-01
DK53780A (da) 1980-08-17
GB2117774A (en) 1983-10-19
ES8102134A1 (es) 1980-12-16
IL59391A0 (en) 1980-05-30
GB2117774B (en) 1984-03-21
US4477448A (en) 1984-10-16
ATA78780A (de) 1983-10-15
IT8047922A0 (it) 1980-02-15
MY8500128A (en) 1985-12-31
ES497002A0 (es) 1982-04-01
SE8500589D0 (sv) 1985-02-08
CA1161032A (en) 1984-01-24
GB8309730D0 (en) 1983-05-18
AT374806B (de) 1984-06-12
GB2046734A (en) 1980-11-19
PT70834A (en) 1980-03-01
IE800284L (en) 1980-08-16
NL8000894A (nl) 1980-08-19
DE3005012A1 (de) 1980-11-27
IE49395B1 (en) 1985-10-02
ES488651A0 (es) 1980-12-16
IL59391A (en) 1983-05-15
GB2046734B (en) 1983-09-01
YU40280A (en) 1983-06-30
SE8000982L (sv) 1980-08-17
PH17926A (en) 1985-01-31

Similar Documents

Publication Publication Date Title
BR8002583A (US07534539-20090519-C00127.png)
BR8006808A (US07534539-20090519-C00127.png)
FR2449093B1 (US07534539-20090519-C00127.png)
AT364253B (US07534539-20090519-C00127.png)
FR2450637B1 (US07534539-20090519-C00127.png)
AU78569S (US07534539-20090519-C00127.png)
AU79557S (US07534539-20090519-C00127.png)
AU78385S (US07534539-20090519-C00127.png)
AU78386S (US07534539-20090519-C00127.png)
AU78389S (US07534539-20090519-C00127.png)
AU78390S (US07534539-20090519-C00127.png)
AU78391S (US07534539-20090519-C00127.png)
AU78270S (US07534539-20090519-C00127.png)
AU79200S (US07534539-20090519-C00127.png)
AU78271S (US07534539-20090519-C00127.png)
AU79558S (US07534539-20090519-C00127.png)
AU79559S (US07534539-20090519-C00127.png)
AU79826S (US07534539-20090519-C00127.png)
AU79918S (US07534539-20090519-C00127.png)
AU79950S (US07534539-20090519-C00127.png)
AU80228S (US07534539-20090519-C00127.png)
AU77763S (US07534539-20090519-C00127.png)
BR5901094U (US07534539-20090519-C00127.png)
AU77669S (US07534539-20090519-C00127.png)
BG28376A1 (US07534539-20090519-C00127.png)

Legal Events

Date Code Title Description
ST Notification of lapse